trending Market Intelligence /marketintelligence/en/news-insights/trending/ea1BcEK0Lo5DgfX3GxhYwA2 content esgSubNav
In This List

Bellerophon Therapeutics principal financial officer to resign

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Bellerophon Therapeutics principal financial officer to resign

Megan Schoeps intends to resign as Bellerophon Therapeutics Inc.'s controller and principal financial officer to pursue other career interests.

Schoeps is expected to continue in her current role until about January 2018 while the company completes an ongoing search for a replacement. She is also expected to provide transition assistance, as needed.